Opendata, web and dolomites

MUSIC SIGNED

Multisystem Cell Therapy for Improvement of Urinary Continence

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MUSIC project word cloud

Explore the words cloud of the MUSIC project. It provides you a very rough idea of what is the project "MUSIC" about.

medicine    medicinal    mpc    manufacturing    option    quality    worldwide    facilitated    burden    prevalence    stress    urinary    therapeutic    50    nmes    life    totally    injection    underlying    music    multilevel    thereby    optimization    200    ultimate    precise    restoration    combination    treatment    offers    urology    patients    mpcs    disease    cell    commercial    people    feasibility    muscle    first    companies    smaller    complications    translating    efficacy    effect    man    multisystem    xeno    atmp    sphincter    efficient    clinic    sui    socio    pathologic    additional    reproducibility    strategies    economic    biomaterials    undertaking    electromagnetic    stem    regenerative    carry    exclusive    therapy    clinical    combining    reverse    centers    introduction    implantation    cells    women    prove    alternative    neuromuscular    technique    incontinence    ideal    stimulation    opportunity    relief    functional    safety    ch    infrastructure    precursor    personalized    free    entail    immense    expertise    validity    basic    engineering    feasible    nl    uk    cellular    final    damaged    biology    million    experts    tissue    autologous    significantly    female    expanding    rm   

Project "MUSIC" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITAT ZURICH 

Organization address
address: RAMISTRASSE 71
city: ZURICH
postcode: 8006
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Project website http://www.music2020.ch
 Total cost 6˙623˙628 €
 EC max contribution 2˙349˙521 € (35%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SC1-2016-RTD
 Funding Scheme RIA
 Starting year 2017
 Duration (year-month-day) from 2017-01-01   to  2021-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITAT ZURICH CH (ZURICH) coordinator 0.00
2    SCINUS HOLDING BV NL (BILTHOVEN) participant 1˙024˙600.00
3    EBERHARD KARLS UNIVERSITAET TUEBINGEN DE (TUEBINGEN) participant 575˙223.00
4    COLLAGEN SOLUTIONS (UK) LIMITED UK (GLASGOW) participant 562˙197.00
5    PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG - PRIVATSTIFTUNG AT (SALZBURG) participant 187˙500.00
6    KUROS BIOSCIENCES BV NL (BILTHOVEN) participant 0.00

Map

 Project objective

'Stress Urinary Incontinence (SUI) is a disease affecting over 200 million people worldwide. It represents a condition with a prevalence of 20-50% in women, thereby creating an immense socio-economic burden. The currently available treatment strategies entail various complications and offer only short-term relief to the patients. Tissue engineering using autologous cells offers a feasible alternative for functional restoration of the damaged urinary sphincter muscle and represents an ideal treatment option that could reverse the underlying pathologic conditions. MUSIC aims at translating basic knowledge on regenerative medicine (RM) and stem cell therapy into the clinic by undertaking a 'first-in-man' multisystem study using autologous muscle precursor cells (MPCs) in a combination with neuromuscular electromagnetic stimulation (NMES) in 40 female patients. We will carry out the specific tasks to prove safety and efficacy of the proposed novel multilevel treatment as well as reproducibility of the therapeutic effect. Additional objectives are optimization of the advanced-therapy medicinal product (ATMP) towards totally xeno-free and facilitated manufacturing as well as the introduction of a novel injection technique for more efficient and precise implantation of the final product. Combining expertise, MUSIC features a unique infrastructure, including the knowledge of experts in the fields of RM, urology, cellular biology and biomaterials throughout Europe (CH, NL, UK, A, D). The MUSIC consortium has an exclusive opportunity to determine the validity of this MPC cellular treatment in combination with NMES and to further improve its feasibility and clinical efficacy. The ultimate goal is to significantly improve the patients` quality of life and to exploit a future commercial opportunity by expanding the know-how to various smaller RM centers and companies within Europe, thus, making personalized medicine using autologous cells a more feasible SUI treatment option.

'

 Deliverables

List of deliverables.
Definition of the best option for delivery of MPCs Demonstrators, pilots, prototypes 2020-02-07 12:51:28
Cell jet injection established and evaluated in vitro and in vivo Demonstrators, pilots, prototypes 2020-02-07 12:51:25
CE Certification of Injection Device Documents, reports 2019-11-25 11:25:55
Project webpage online Websites, patent fillings, videos etc. 2019-11-25 11:25:55

Take a look to the deliverables list in detail:  detailed list of MUSIC deliverables.

 Publications

year authors and title journal last update
List of publications.
2019 Sandra Laner-Plamberger, Michaela Oeller, Rodolphe Poupardin, Linda Krisch, Sarah Hochmann, Ravi Kalathur, Karin Pachler, Christina Kreutzer, Gerrit Erdmann, Eva Rohde, Dirk Strunk, Katharina Schallmoser
Heparin Differentially Impacts Gene Expression of Stromal Cells from Various Tissues
published pages: , ISSN: 2045-2322, DOI: 10.1038/s41598-019-43700-x
Scientific Reports 9/1 2020-03-05
2019 Luise Jäger, Walter Linzenbold, Andreas Fech, Markus Enderle, Tanja Abruzzese, Arnulf Stenzl, Wilhelm K. Aicher
A novel waterjet technology for transurethral cystoscopic injection of viable cells in the urethral sphincter complex
published pages: 594-602, ISSN: 0733-2467, DOI: 10.1002/nau.24261
Neurourology and Urodynamics 39/2 2020-03-05
2019 Sandra Laner-Plamberger, Michaela Oeller, Cornelia Mrazek, Arnulf Hartl, Alina Sonderegger, Eva Rohde, Dirk Strunk, Katharina Schallmoser
Upregulation of mitotic bookmarking factors during enhanced proliferation of human stromal cells in human platelet lysate
published pages: , ISSN: 1479-5876, DOI: 10.1186/s12967-019-02183-0
Journal of Translational Medicine 17/1 2020-03-05
2020 Désirée Forstner, Sabine Maninger, Olivia Nonn, Jacqueline Guettler, Gerit Moser, Gerd Leitinger, Elisabeth Pritz, Dirk Strunk, Katharina Schallmoser, Gunther Marsche, Akos Heinemann, Berthold Huppertz, Martin Gauster
Platelet-derived factors impair placental chorionic gonadotropin beta-subunit synthesis
published pages: 193-207, ISSN: 0946-2716, DOI: 10.1007/s00109-019-01866-x
Journal of Molecular Medicine 98/2 2020-03-05
2018 D. Strunk, M. Lozano, D.C. Marks, Y. S. Loh, G. Gstraunthaler, H. Schennach, E. Rohde, S. Laner-Plamberger, M. Öller, J. Nystedt, R. Lotfi, M. Rojewski, H. Schrezenmeier, K. Bieback, R. Schäfer, T. Bakchoul, M. Waidmann, S.M. Jonsdottir-Buch, H. Montazeri, O.E. Sigurjonsson, P. Iudicone, D. Fioravanti, L. Pierelli, M. Introna, C. Capelli, A. Falanga, M. Takanashi, O. Lόpez-Villar, T. Burnouf, J. A. Reems, J. Pierce, A.M. Preslar, K. Schallmoser
International Forum on GMP-grade human platelet lysate for cell propagation: summary
published pages: 80-87, ISSN: 0042-9007, DOI: 10.1111/vox.12593
Vox Sanguinis 113/1 2019-11-25
2017 Andreas Reinisch, David Cruz Hernandez, Katharina Schallmoser, Ravindra Majeti
Generation and use of a humanized bone-marrow-ossicle niche for hematopoietic xenotransplantation into mice
published pages: 2169-2188, ISSN: 1754-2189, DOI: 10.1038/nprot.2017.088
Nature Protocols 12/10 2019-11-25
2018 Michaela Oeller, Sandra Laner-Plamberger, Sarah Hochmann, Nina Ketterl, Martina Feichtner, Gabriele Brachtl, Anna Hochreiter, Cornelia Scharler, Lara Bieler, Pasquale Romanelli, Sebastien Couillard-Despres, Elisabeth Russe, Katharina Schallmoser, Dirk Strunk
Selection of Tissue Factor-Deficient Cell Transplants as a Novel Strategy for Improving Hemocompatibility of Human Bone Marrow Stromal Cells
published pages: 1421-1434, ISSN: 1838-7640, DOI: 10.7150/thno.21906
Theranostics 8/5 2019-11-25

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MUSIC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MUSIC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

ISLET (2020)

Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe

Read More  

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More